Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH I study

Helicobacter

Volumn 1, Issue 3, 1996, Pages 138-144

  Lind, Tore ^a   Van Zanten, Sander Veldhuyzen ^b   Unge, Peter ^c   Spiller, Robin ^d   Bayerdörffer, Ekkehard ^e   O'Morain, Colm ^f   Bardhan, Karna Dev ^g   Bradette, Marc ^h   Chiba, Naoki ⁱ   Wrangstadh, Michael ^j   Cederberg, Christer ^j   Idström, Jan Peter ^j  

^a Karnsjukhuset   (Sweden)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^c Sandviken Hospital   (Sweden)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f ADELAIDE AND MEATH HOSPITAL   (Ireland)

^g ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^h Hôpital Christ Roi Vanier   (Canada)

ⁱ Surrey Gl Clinic   (Canada)

^j ASTRAZENECA R AND D   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIULCER AGENT; CLARITHROMYCIN; ENZYME INHIBITOR; METRONIDAZOLE; OMEPRAZOLE;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; DUODENUM ULCER; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AMOXICILLIN; ANTI-ULCER AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DUODENAL ULCER; ENZYME INHIBITORS; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; TREATMENT OUTCOME;

EID: 0030223132     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1996.tb00027.x     Document Type: Article

References (25)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89:S116-28.
2. O'Connor HJ. The role of Helicobacter pylori in peptic ulcer disease. Scand J Gastroenterol 1994;29(suppl 201):11-15.
3. Axon ATR, Quina M. Ten-year milestones. Curr Opin Gastroenterol 1994;10 (suppl 1):1-5.
4. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
5. Blum AL. Treatment of acid-related disorders with gastric acid inhibitors: the state of the art. Digestion 1990;47(suppl 1):3-10.
6. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? Gastroenterology 1990;99:345-51.
7. 2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: A meta-analysis. Eur J Gastroenterol Hepatol 1995;7:467-75.
8. Labenz J, Gyenes E, Rühl E, Börsch G. Amoxycillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective randomized and controlled study. Gut 1993;34:1167-70.
9. Tytgat GNJ. Review article: Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.
10. Axon ATR. Role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994;29(suppl 201):16-23.
11. Bayerdörffer E, Miehlke S, Mannes GA, Sommer A, Hochter W, Weingart J, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcer. Gastroenterology 1995;108:1412-7.
12. Logan RPH, Gummett PA, Schaufelberger HD, Greaves RR, Mendelson GM, Walker MM, et al. Eradication of H. pylori with clarithromycin and omeprazole. Gut 1994;35:323-6.
13. O'Morain C, Logan RPH, and the Clarithromycin European H. pylori Study Group. Clarithromycin in combination with omeprazole for healing of duodenal ulcers, prevention of DU recurrence, and eradication of H. pylori in two European studies. Gastroenterology 1995;108:(4):A184.
14. Lamouliatte HC, Cayla R, Mégraud F, Stablo M, Bouchard S, Quinton A. Amoxicillin and omeprazole: The best therapy for Helicobacter pylori infection? Acta Gastro-Enterologica Belgica 1993;56(suppl):140.
15. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
16. Moayyedi P, Axon ATR. Efficacy of a new one week therapy regime in eradicating Helicobacter pylori. Gut 1994;35(suppl 2):S62.
17. Bell GD, Powell KU, Burridge SM, Bowden AN, Rameh B, Bolton G, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:41-6.
18. Goddard A, Logan R. 1-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995;7:1-3.
19. 13C-urea breath test. In: Rathbone BJ, Heatley RV, eds. Helicobacter pylori and Gastroduodenal Disease (2nd Edition). Oxford: Blackwell Scientific, 1992;88-106.
20. Medicines Control Agency. Biostatistical methodology in clinical trials in applications for marketing authorisations for medicinal products. (Euro Direct publications no. 3630/92.) London: Medicines Control Agency, 1992;16-19.
21. Verdu EF, Fraser R, Armstrong D, Blum AL. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers. Scand J Gastroenterol 1994;29:1065-9.
22. Unge P, Gad A, Gnarpe H, Olsson J. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol 1989;24(suppl 167):49-54.
23. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-840.
24. Atherton JC, Spiller RC. The urea, breath test for Helicobacter pylori. Gut 1994;36:723-5.
25. Glupczinski Y, Burette A, De Koster E, Nyst JF, Deltenre M, Cadranel S, et al. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 1:976-7.